Apart from its role in neurodegenerative disorders, numerous studies have suggested that PARK7 acts as a mitogen-dependent oncogene that plays a crucial role in the progression of various types of cancer and has been identified as a novel oncoprotein involved in the Ras transduction pathway [25] (Table 1). This evidence concerns the gene PARK7 and cancer.